Rapport Therapeutics, Inc. · NASDAQ:RAPP

Gault Cheryl sold 10,000 Rapport Therapeutics, Inc. shares (Form 4)

Traded Jun 30, 2026 · Filed Jul 1, 2026

On Jun 30, 2026, Gault Cheryl (Chief Operating Officer) sold 10,000 Rapport Therapeutics, Inc. shares at an average US$41.58 for US$416K under a trading plan, leaving 149,914 shares. Filed Jul 1, 2026 (Form 4).

Sold: 10,000 shares
Price: US$41.58 average (US$40.09 to US$43.15)
Value: US$416K
Holding after: 149,914 shares
Trading plan: Yes (Made under a plan set in advance)
Role: Chief Operating Officer

The filing in full

Date	Security	Transaction	Shares	Price	Holding after	Ownership
Jun 30, 2026	Common Stock	Sale	1,900	US$40.09	158,014	Direct
Jun 30, 2026	Common Stock	Sale	3,792	US$41.39	154,222	Direct
Jun 30, 2026	Common Stock	Sale	3,308	US$42.17	150,914	Direct
Jun 30, 2026	Common Stock	Sale	1,000	US$43.15	149,914	Direct

Source

View original at SEC

Related